Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cantor Fitzgerald
Merck
Colorcon
McKesson
Cipla
Dow
Accenture
Julphar

Generated: May 21, 2018

DrugPatentWatch Database Preview

SUCRALFATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Sucralfate patents expire, and when can generic versions of Sucralfate launch?

Sucralfate is a drug marketed by Mylan Ireland Ltd and Teva and is included in two NDAs.

The generic ingredient in SUCRALFATE is sucralfate. There are fourteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the sucralfate profile page.
Summary for SUCRALFATE
Drug patent expirations by year for SUCRALFATE
Pharmacology for SUCRALFATE
Medical Subject Heading (MeSH) Categories for SUCRALFATE

US Patents and Regulatory Information for SUCRALFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Ireland Ltd SUCRALFATE sucralfate TABLET;ORAL 074415-001 Jun 8, 1998 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva SUCRALFATE sucralfate TABLET;ORAL 070848-001 Mar 29, 1996 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Farmers Insurance
McKinsey
Cipla
Dow
Colorcon
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.